The Russian federal government is planning a substantial reduction in its national cancer care budget over the next several years. According to recent budget reports, funding for the federal cancer program is set to drop from 44.9 billion roubles in 2025 to 3.87 billion roubles by 2027. This represents a nearly 40-fold decrease in financial support for the initiative.

This shift in fiscal policy coincides with a historic increase in military spending. Defense expenditures are projected to account for 35% of the total federal budget, marking the highest share of military spending in Russia since the collapse of the Soviet Union. The reallocation of funds suggests a prioritization of national security and ongoing military operations over domestic healthcare infrastructure.

While the figures clearly indicate a contraction in cancer care funding, the long-term impact on patient access to treatment remains a subject of concern for health policy analysts. The government has not yet provided detailed explanations on how regional healthcare systems will compensate for the loss of federal support, or whether alternative funding streams will be established to mitigate the impact on oncology services.